Athanasios Zavras, DDS, DMD, DScM
Professor
Boston University Henry M. Goldman School of Dental Medicine
Dept of Pediatric Dentistry

DDS, Columbia University
DMD, Univ of Athens
DScM, Harvard School of Public Health
MSc, Harvard School of Public Health



Dr. Zavras holds: a DMD degree from the University of Athens School of Dental Medicine in 1991; a Certificate of Advanced Specialty Education in Pediatric Dentistry from Tufts University School of Dental Medicine in 1993; an MSc in Epidemiology from Harvard University School of Public Health in 1994; a Certificate of Advanced Studies in Oral Epidemiology from Harvard University School of Dental Medicine in 1998; a Certificate of Advanced Specialty Education in Dental Public Health from the Harvard University School of Dental Medicine in 1999; a DMSc in Oral Biology/Epidemiology from Harvard University in 1999; and a DDS from Columbia University College of Dental Medicine in 2012. He is a Diplomate of the American Board of Dental Public Health and is licensed by both the Massachusetts and New York State Dental Boards.

Prior to accepting this appointment at Boston University, Dr. Zavras served on the faculties of the Columbia College of Dental Medicine and the Mailman School of Public Health (2009-2014) as Professor of Dental Medicine and Epidemiology, Division Head for Oral Epidemiology & Biostatistics, and Director of Dental Public Health. In addition, he has served as a Senior Clinical Investigator at Forsyth Research Center since 2008 and Adjunct Professor at Harvard University School of Public Health since 2009.

Prior to Columbia University, Dr. Zavras was at Harvard from 1999 to 2009. He was: a Lecturer at the School of Dental Medicine in 1999; an Assistant Professor of Oral Health Policy & Epidemiology at the School of Dental Medicine from 2000 to 2007; and an Associate Professor of Oral Health Policy & Epidemiology at the School of Dental Medicine and of Epidemiology at the School of Public Health from 2007 to 2009. He took a leave of absence from Harvard from 2004 – 2005 to serve as Senior Scientist at Ingenix, United HealthCare. Prior to that, he was a part time Clinical Associate in Pediatric Dentistry at Tufts University School of Dental Medicine from 1993 to 1996.

Dr. Zavras has an extensive record of grants and awards. Currently, he is principal investigator in an industry-funded project and co-investigator on four HRSA (Health Resources and Services Administration) grants. He holds a patent for genetic risk assessment technology for epithelial cancer involving gene-environment interaction and has two additional patents pending. In addition to his research activities, Dr. Zavras lectures regularly nationally and internationally. He has published prolifically in some of the most prestigious high impact dental and medical journals, including 45 original research articles, 22 reviews, 13 book chapters, and over 34 published abstracts. He also serves on numerous editorial boards.

Dr. Zavras has been an active member of committees and working groups at each institution he has served. He has also served as a member and chair on dozens of national, NIH, and international committees. He has received more than a dozen scholarship, research, and professional awards and is a faculty member of the Omicron Kappa Upsilon Dental Honor Society, Gamma Gamma Chapter.

Dr. Zavras is a member of the American Academy of Pediatric Dentistry, the American Association of Dental Research, the International Association of Dental Research, the American Association of Public Health Dentistry, the Center for Disease Control and Prevention Human Genetics Network (HUGE NET), the American Dental Association, the New York State Dental Association, and the International Society for the Prevention of Tobacco Induced Diseases, where he held several leadership positions, including: Executive Committee Member from 2002 to 2007; Head of the Americas from 2003 to 2004; and President from 2004 to 2005. He is also a Fellow of the New York Academy of Medicine (NYAM).

Chair
Boston University Henry M. Goldman School of Dental Medicine
Pediatric Dentistry




An Observational Case Control Study to Validate the Association between RBMS3 and Risk of Osteonecrosis of the Jaw in Cancer Patients Receiving Intravenous Bisphosphonates or Denosumab
08/12/2015 - 08/11/2016 (PI)
Merck, Sharp & Dohme Corp




Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Zavras D, Zavras AI, Kyriopoulos II, Kyriopoulos J. Economic crisis, austerity and unmet healthcare needs: the case of Greece. BMC Health Serv Res. 2016 Jul 27; 16:309. PMID: 27460938; PMCID: PMC4962475; DOI: 10.1186/s12913-016-1557-5;.
  2. Zavras AI, Shanmugham JR. Bisphosphonates, Osteoporosis, and Osteonecrosis of the Jaw: A Critical Review of a Large Nested Case-Control Study. J Evid Based Dent Pract. 2016 Jun; 16(2):136-8. PMID: 27449847; DOI: 10.1016/j.jebdp.2016.05.007;.
  3. Zavras AI. "Teeth are always in style": but increasingly, not for all. Health Serv Res. 2014 Apr; 49(2):453-9. PMID: 24673514; DOI: 10.1111/1475-6773.12172a;.
  4. Zavras AI, Rosenberg GE, Danielson JD, Cartsos VM. Adverse drug and device reactions in the oral cavity: surveillance and reporting. J Am Dent Assoc. 2013 Sep; 144(9):1014-21. PMID: 23989840.
  5. Zavras AI, Shanmugam P, Shetty D, Dolecek TA, Kaste LM. Oral and pharyngeal cancer in women. Dent Clin North Am. 2013 Apr; 57(2):339-55. PMID: 23570809; DOI: 10.1016/j.cden.2013.02.001;.
  6. Koo J, Zavras A. Antiepileptic drugs (AEDs) during pregnancy and risk of congenital jaw and oral malformation. Oral Dis. 2013 Oct; 19(7):712-20. PMID: 23305414; DOI: 10.1111/odi.12061;.
  7. Zavras AI, Yoon AJ, Chen MK, Lin CW, Yang SF. Association between polymorphisms of DNA repair gene ERCC5 and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Nov; 114(5):624-9. PMID: 22981091; DOI: 10.1016/j.oooo.2012.05.013;.
  8. Zavras AI. Pharmacogenetics to screen for drug-induced osteonecrosis of the jaw. Pharmacogenomics. 2012 Jul; 13(9):985-7. PMID: 22838944; DOI: 10.2217/pgs.12.63;.
  9. Tennis P, Rothman KJ, Bohn RL, Tan H, Zavras A, Laskarides C, Calingaert B, Anthony MS. Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis. Pharmacoepidemiol Drug Saf. 2012 Aug; 21(8):810-7.View Related Profiles. PMID: 22711458; DOI: 10.1002/pds.3292;.
  10. Dangi J, Kinnunen TH, Zavras AI. Challenges in global improvement of oral cancer outcomes: findings from rural Northern India. Tob Induc Dis. 2012; 10:5. PMID: 22494988; PMCID: PMC3352301; DOI: 10.1186/1617-9625-10-5;.
Showing 10 of 54 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 54 publications over 19 distinct years, with a maximum of 7 publications in 2002

YearPublications
19942
19971
19991
20004
20011
20027
20033
20042
20052
20064
20072
20083
20091
20105
20115
20125
20133
20141
20162
Contact for Mentoring:


100 E. Newton St Goldman SDM
Boston MA 02118
Google Map


Zavras's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department